Literature DB >> 23715905

Automated analysis of FDG PET as a tool for single-subject probabilistic prediction and detection of Alzheimer's disease dementia.

Javier Arbizu1, E Prieto, P Martínez-Lage, J M Martí-Climent, M García-Granero, I Lamet, P Pastor, M Riverol, M T Gómez-Isla, I Peñuelas, J A Richter, M W Weiner.   

Abstract

PURPOSE: To introduce, evaluate and validate a voxel-based analysis method of ¹⁸F-FDG PET imaging for determining the probability of Alzheimer's disease (AD) in a particular individual.
METHODS: The subject groups for model derivation comprised 80 healthy subjects (HS), 36 patients with mild cognitive impairment (MCI) who converted to AD dementia within 18 months, 85 non-converter MCI patients who did not convert within 24 months, and 67 AD dementia patients with baseline FDG PET scan were recruited from the AD Neuroimaging Initiative (ADNI) database. Additionally, baseline FDG PET scans from 20 HS, 27 MCI and 21 AD dementia patients from our institutional cohort were included for model validation. The analysis technique was designed on the basis of the AD-related hypometabolic convergence index adapted for our laboratory-specific context (AD-PET index), and combined in a multivariable model with age and gender for AD dementia detection (AD score). A logistic regression analysis of different cortical PET indexes and clinical variables was applied to search for relevant predictive factors to include in the multivariable model for the prediction of MCI conversion to AD dementia (AD-Conv score). The resultant scores were stratified into sixtiles for probabilistic diagnosis.
RESULTS: The area under the receiver operating characteristic curve (AUC) for the AD score detecting AD dementia in the ADNI database was 0.879, and the observed probability of AD dementia in the six defined groups ranged from 8% to 100% in a monotonic trend. For predicting MCI conversion to AD dementia, only the posterior cingulate index, Mini-Mental State Examination (MMSE) score and apolipoprotein E4 genotype (ApoE4) exhibited significant independent effects in the univariable and multivariable models. When only the latter two clinical variables were included in the model, the AUC was 0.742 (95% CI 0.646 - 0.838), but this increased to 0.804 (95% CI 0.714 - 0.894, bootstrap p=0.027) with the addition of the posterior cingulate index (AD-Conv score). Baseline clinical diagnosis of MCI showed 29.7% of converters after 18 months. The observed probability of conversion in relation to baseline AD-Conv score was 75% in the high probability group (sixtile 6), 34% in the medium probability group (merged sixtiles 4 and 5), 20% in the low probability group (sixtile 3) and 7.5% in the very low probability group (merged sixtiles 1 and 2). In the validation population, the AD score reached an AUC of 0.948 (95% CI 0.625 - 0.969) and the AD-Conv score reached 0.968 (95% CI 0.908 - 1.000), with AD patients and MCI converters included in the highest probability categories.
CONCLUSION: Posterior cingulate hypometabolism, when combined in a multivariable model with age and gender as well as MMSE score and ApoE4 data, improved the determination of the likelihood of patients with MCI converting to AD dementia compared with clinical variables alone. The probabilistic model described here provides a new tool that may aid in the clinical diagnosis of AD and MCI conversion.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23715905     DOI: 10.1007/s00259-013-2458-z

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  37 in total

1.  Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET.

Authors:  K Herholz; E Salmon; D Perani; J C Baron; V Holthoff; L Frölich; P Schönknecht; K Ito; R Mielke; E Kalbe; G Zündorf; X Delbeuck; O Pelati; D Anchisi; F Fazio; N Kerrouche; B Desgranges; F Eustache; B Beuthien-Baumann; C Menzel; J Schröder; T Kato; Y Arahata; M Henze; W D Heiss
Journal:  Neuroimage       Date:  2002-09       Impact factor: 6.556

2.  Dementia: new criteria but no new treatments.

Authors:  Reisa A Sperling; Keith A Johnson
Journal:  Lancet Neurol       Date:  2012-01       Impact factor: 44.182

3.  CSF and MRI markers independently contribute to the diagnosis of Alzheimer's disease.

Authors:  Niki S M Schoonenboom; Wiesje M van der Flier; Marinus A Blankenstein; Femke H Bouwman; Gerard J Van Kamp; Frederik Barkhof; Philip Scheltens
Journal:  Neurobiol Aging       Date:  2007-01-17       Impact factor: 4.673

4.  Resting metabolic connectivity in prodromal Alzheimer's disease. A European Alzheimer Disease Consortium (EADC) project.

Authors:  Silvia Morbelli; Alex Drzezga; Robert Perneczky; Giovanni B Frisoni; Anna Caroli; Bart N M van Berckel; Rik Ossenkoppele; Eric Guedj; Mira Didic; Andrea Brugnolo; Gianmario Sambuceti; Marco Pagani; Eric Salmon; Flavio Nobili
Journal:  Neurobiol Aging       Date:  2012-02-23       Impact factor: 4.673

5.  Summary metrics to assess Alzheimer disease-related hypometabolic pattern with 18F-FDG PET: head-to-head comparison.

Authors:  Anna Caroli; Annapaola Prestia; Kewei Chen; Napatkamon Ayutyanont; Susan M Landau; Cindee M Madison; Cathleen Haense; Karl Herholz; Flavio Nobili; Eric M Reiman; William J Jagust; Giovanni B Frisoni
Journal:  J Nucl Med       Date:  2012-02-17       Impact factor: 10.057

6.  Functional implications of hippocampal degeneration in early Alzheimer's disease: a combined DTI and PET study.

Authors:  Igor Yakushev; Matthias Schreckenberger; Matthias J Müller; Ingrid Schermuly; Paul Cumming; Peter Stoeter; Alex Gerhard; Andreas Fellgiebel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-07-27       Impact factor: 9.236

7.  A new rating scale for age-related white matter changes applicable to MRI and CT.

Authors:  L O Wahlund; F Barkhof; F Fazekas; L Bronge; M Augustin; M Sjögren; A Wallin; H Ader; D Leys; L Pantoni; F Pasquier; T Erkinjuntti; P Scheltens
Journal:  Stroke       Date:  2001-06       Impact factor: 7.914

8.  Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade.

Authors:  Clifford R Jack; David S Knopman; William J Jagust; Leslie M Shaw; Paul S Aisen; Michael W Weiner; Ronald C Petersen; John Q Trojanowski
Journal:  Lancet Neurol       Date:  2010-01       Impact factor: 44.182

9.  Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease.

Authors:  A Drzezga; T Grimmer; G Henriksen; M Mühlau; R Perneczky; I Miederer; C Praus; C Sorg; A Wohlschläger; M Riemenschneider; H J Wester; H Foerstl; M Schwaiger; A Kurz
Journal:  Neurology       Date:  2009-04-01       Impact factor: 9.910

10.  MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET.

Authors:  L Mosconi; D Perani; S Sorbi; K Herholz; B Nacmias; V Holthoff; E Salmon; J-C Baron; M T R De Cristofaro; A Padovani; B Borroni; M Franceschi; L Bracco; A Pupi
Journal:  Neurology       Date:  2004-12-28       Impact factor: 9.910

View more
  18 in total

Review 1.  Clinical utility of FDG-PET for the clinical diagnosis in MCI.

Authors:  Javier Arbizu; Cristina Festari; Daniele Altomare; Zuzana Walker; Femke Bouwman; Jasmine Rivolta; Stefania Orini; Henryk Barthel; Federica Agosta; Alexander Drzezga; Peter Nestor; Marina Boccardi; Giovanni Battista Frisoni; Flavio Nobili
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-04-27       Impact factor: 9.236

Review 2.  A Cochrane review on brain [¹⁸F]FDG PET in dementia: limitations and future perspectives.

Authors:  Silvia Morbelli; Valentina Garibotto; Elsmarieke Van De Giessen; Javier Arbizu; Gaël Chételat; Alexander Drezgza; Swen Hesse; Adriaan A Lammertsma; Ian Law; Sabina Pappata'; Pierre Payoux; Marco Pagani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-09       Impact factor: 9.236

3.  Visual and statistical analysis of ¹⁸F-FDG PET in primary progressive aphasia.

Authors:  Jordi A Matías-Guiu; María Nieves Cabrera-Martín; María Jesús Pérez-Castejón; Teresa Moreno-Ramos; Cristina Rodríguez-Rey; Rocío García-Ramos; Aida Ortega-Candil; Marta Fernandez-Matarrubia; Celia Oreja-Guevara; Jorge Matías-Guiu; José Luis Carreras
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-02-03       Impact factor: 9.236

4.  Early identification of MCI converting to AD: a FDG PET study.

Authors:  Marco Pagani; Flavio Nobili; Silvia Morbelli; Dario Arnaldi; Alessandro Giuliani; Johanna Öberg; Nicola Girtler; Andrea Brugnolo; Agnese Picco; Matteo Bauckneht; Roberta Piva; Andrea Chincarini; Gianmario Sambuceti; Cathrine Jonsson; Fabrizio De Carli
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-06-29       Impact factor: 9.236

Review 5.  2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception.

Authors:  Michael W Weiner; Dallas P Veitch; Paul S Aisen; Laurel A Beckett; Nigel J Cairns; Jesse Cedarbaum; Robert C Green; Danielle Harvey; Clifford R Jack; William Jagust; Johan Luthman; John C Morris; Ronald C Petersen; Andrew J Saykin; Leslie Shaw; Li Shen; Adam Schwarz; Arthur W Toga; John Q Trojanowski
Journal:  Alzheimers Dement       Date:  2015-06       Impact factor: 21.566

6.  Visual Rating and Computer-Assisted Analysis of FDG PET in the Prediction of Conversion to Alzheimer's Disease in Mild Cognitive Impairment.

Authors:  Jae Myeong Kang; Jun-Young Lee; Yu Kyeong Kim; Bo Kyung Sohn; Min Soo Byun; Ji Eun Choi; Soo Kyung Son; Hyung-Jun Im; Jae-Hoon Lee; Young Hoon Ryu; Dong Young Lee
Journal:  Mol Diagn Ther       Date:  2018-08       Impact factor: 4.074

7.  Detection of subjects and brain regions related to Alzheimer's disease using 3D MRI scans based on eigenbrain and machine learning.

Authors:  Yudong Zhang; Zhengchao Dong; Preetha Phillips; Shuihua Wang; Genlin Ji; Jiquan Yang; Ti-Fei Yuan
Journal:  Front Comput Neurosci       Date:  2015-06-02       Impact factor: 2.380

8.  Genome-wide association study identifies RBFOX1 locus influencing brain glucose metabolism.

Authors:  Ling-Li Kong; Dan Miao; Lin Tan; Shu-Lei Liu; Jie-Qiong Li; Xi-Peng Cao; Lan Tan
Journal:  Ann Transl Med       Date:  2018-11

9.  Detection of Alzheimer's disease by displacement field and machine learning.

Authors:  Yudong Zhang; Shuihua Wang
Journal:  PeerJ       Date:  2015-09-17       Impact factor: 2.984

Review 10.  A survey of FDG- and amyloid-PET imaging in dementia and GRADE analysis.

Authors:  Daniela Perani; Perani Daniela; Orazio Schillaci; Schillaci Orazio; Alessandro Padovani; Padovani Alessandro; Flavio Mariano Nobili; Nobili Flavio Mariano; Leonardo Iaccarino; Iaccarino Leonardo; Pasquale Anthony Della Rosa; Della Rosa Pasquale Anthony; Giovanni Frisoni; Frisoni Giovanni; Carlo Caltagirone; Caltagirone Carlo
Journal:  Biomed Res Int       Date:  2014-03-19       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.